Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant

This publication has 24 references indexed in Scilit:

• Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice
  Microbiology and Immunology, 2008
• Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
  PLOS ONE, 2008
• Live Poultry Exposures, Hong Kong and Hanoi, 2006
  Emerging Infectious Diseases, 2007
• Recombinant Modified Vaccinia Virus Ankara–Based Vaccine Induces Protective Immunity in Mice against Infection with Influenza Virus H5N1
  The Journal of Infectious Diseases, 2007
• Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
  JAMA, 2006
• Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria–pertussis–tetanus (DPT) combination vaccine
  Vaccine, 2004
• Baculovirus Induces an Innate Immune Response and Confers Protection from Lethal Influenza Virus Infection in Mice
  The Journal of Immunology, 2003
• Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes
  Gene Therapy, 2000
• Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant
  Vaccine, 2000
• Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit
  Vaccine, 1998